Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Study offers genetic explanation why cancer occurs commonly in males than females

Study offers genetic explanation why cancer occurs commonly in males than females

Researchers discover protein complex that enables 'quality control' of immune T cells

Researchers discover protein complex that enables 'quality control' of immune T cells

Implementation of large-scale genomic tumor profiling viable but faces several challenges

Implementation of large-scale genomic tumor profiling viable but faces several challenges

Researchers create first mouse model for common form of infant leukemia

Researchers create first mouse model for common form of infant leukemia

CHLA researchers receive TRP grant to study new way of combating relapsed ALL

CHLA researchers receive TRP grant to study new way of combating relapsed ALL

SMU virologist receives NCI grant to advance research into how certain viruses cause cancers

SMU virologist receives NCI grant to advance research into how certain viruses cause cancers

ASH partners with other organizations to address knowledge gaps in AML care

ASH partners with other organizations to address knowledge gaps in AML care

Researchers uncover possible targeted therapy for new, high-risk subtype of ALL

Researchers uncover possible targeted therapy for new, high-risk subtype of ALL

Study finds lack of improvement in health status of childhood cancer survivors

Study finds lack of improvement in health status of childhood cancer survivors

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

WSU researcher finds a way to reduce development of cancer cells

WSU researcher finds a way to reduce development of cancer cells

Problems with nuclear membrane play role in leukemia, heart disease and aging disorders

Problems with nuclear membrane play role in leukemia, heart disease and aging disorders

Scientists discover novel therapeutic target and treatment strategy for acute myeloid leukemia

Scientists discover novel therapeutic target and treatment strategy for acute myeloid leukemia

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

Nano-biointeraction and nanopathology

Nano-biointeraction and nanopathology

Blocking critical molecule with therapeutic antibody could effectively reduce leukemia burden

Blocking critical molecule with therapeutic antibody could effectively reduce leukemia burden

Combination of two drugs could be effective strategy to target T-cell lymphocytic leukemia

Combination of two drugs could be effective strategy to target T-cell lymphocytic leukemia

Novel lipid-based therapeutic shows promise for combating drug resistance in AML

Novel lipid-based therapeutic shows promise for combating drug resistance in AML

New oncogene may contribute to high incidence of prostate cancer among African American men

New oncogene may contribute to high incidence of prostate cancer among African American men

Yale researchers develop new mouse model to understand multiple myeloma

Yale researchers develop new mouse model to understand multiple myeloma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.